You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed arti
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
| Type | Public |
|---|---|
| Industry | HealthTech, Wearable devices |
| Founded | 2019 |
| Founder | Dmytro Gazda, Anna Believantseva, Ihor Ilchenko, Borys Lobanov |
| Headquarters | New York, U.S.A. |
Number of employees | 80+ |
| Website | https://www.esperbionics.com/ |
Esper (also referred to as Esper Bionics)[1] is a deep-tech company that develops wearable technologies, most notably AI-powered robotic hand prostheses.[2] The company was founded in 2019 and is headquartered in New York City, United States, with its engineering, design, and production units based in Kyiv, Ukraine.[3][4]
According to the company, its products are designed to help users better interpret the body's physiological signals, support the restoration of physical function, and enable monitoring of a user's condition.[5] As of July 2026, the company's co-founder and chief operating officer reported approximately 800 users of its devices across the United States and Ukraine combined.[6][7]
The company's first product was the Esper Hand, a bionic hand prosthesis controlled through electromyography. The device was included in TIME magazine's 2022 "Best Inventions" list[8][9] and received a Red Dot Award: Best of the Best for design.[10] The company has announced MARS as its next major product — a multisensory wearable system intended, according to the company, to provide more precise recognition of the body's biosignals and personalized control of other connected devices.[11]
Esper Bionics was founded in 2019 by Dmytro Gazda, Anna Believantseva, Ihor Ilchenko, and Borys Lobanov.[12] In its early stages, the company received grants from the Vernadsky Challenge[13], the Ukrainian Startup Fund[14], and went through the American accelerator program Alchemist. Until 2024, the company's largest investor was the Ukrainian investment firm SMRK.[15]
In February 2022, the company unveiled its flagship product, the Esper Hand, an EMG-controlled prosthetic arm that the company describes as using self-learning algorithms to adapt to individual users over time.[16][17] The product drew international media attention following its launch.[18]

Later in 2022, the Esper Hand was included in TIME magazine's annual "Best Inventions" list and featured on the cover of the corresponding issue. The same year, the product received a Red Dot Award: Best of the Best for design, and it was later recognized as a CES Innovation Award honoree by the Consumer Technology Association (2024 award cycle).[19]
In May 2022, the company launched the Esper for Ukraine program, through which Ukrainian war veterans can receive an Esper Hand prosthesis free of charge, along with support during the fitting and adaptation process.[20] According to the company's website, more than 800 people had received prosthetic care through this program as of the most recent review of the page.[7]

In May 2024, the company received a $150,000 grant from the United States Agency for International Development (USAID), announced by U.S. Secretary of State Antony Blinken during a visit to Kyiv.[21] In June 2024, Esper Bionics raised $5 million in a funding round led by the Munich-based venture capital firm YZR Capital, with participation from the European Bank for Reconstruction and Development (EBRD) and the Chicago-based fund U.Ventures.[22][23] The funds were intended to support expanded production, research and development, and the growth of an integrated "bionic ecosystem" of devices.
The company's core product is the Esper Hand, a robotic hand prosthesis available for both adult and pediatric users.[24] The device is controlled through non-invasive electromyography: sensors placed within the socket that connects to the residual limb detect electrical muscle activity and relay signals that move the prosthetic fingers. It has an anatomical, human-like design and is built with six independent motors and five movable digits, four of which have touchscreen-compatible fingertips, capable of multiple grip types for everyday tasks.[25] The wrist supports 360-degree rotation.[26]
The prosthesis is made from a combination of materials including polyoxymethylene plastic, fluoroplastics, nylon, aluminum, steel, titanium, bronze, and several types of silicone.[27][28]
An important feature of the Esper Hand is its companion mobile application, Esper+, which connects to the device via Bluetooth. The app allows users and prosthetists to customize and reassign grip patterns, calibrate muscle sensor sensitivity, and train the device to better recognize individual movement patterns over time; it also lets users track battery status and, according to the developer, stay in contact with their prosthetist through a connected cloud service.[29][30]
The product is registered with the U.S. Food and Drug Administration (FDA).[31] In the United States, it is sold through health insurers at a price of around $20,000–22,000 per unit.[32]

In May 2025, Esper Bionics unveiled the second generation of its flagship device, the Esper Hand 2, which became available for sale in the United States.[33][34]
According to the company, Esper Hand 2 is designed to be water-resistant, incorporates strengthened aluminum fingers intended to provide a more secure grip, and features larger touch-sensitive surfaces on the fingers for more precise control.[35][36] The device is paired with an updated version of the companion mobile application for customizing grips and monitoring sensor activity.[37]
According to founder and CEO Dmytro Gazda, the company's strategic ambitions extend beyond the prosthetics market. Esper has described the Esper Hand as the starting point for a broader ecosystem of wearable technologies intended to help users better understand the body's signals, restore physical function, and monitor their condition.[22]
The company has announced a next product, MARS, described by the company as a multisensory wearable system intended to recognize biosignals with greater precision and enable personalized control of other devices.[11] According to the company, MARS is intended to incorporate multiple sensors along with updated electronics and control algorithms, with the stated goal of reducing the time needed for users to learn the device and expanding the range of controllable gestures.[11] The company has said it plans to launch MARS first in Ukraine before expanding to the United States, and has suggested the underlying technology could extend beyond bionic prosthetics to broader wearable-device applications.[38]
As of the time of writing, MARS had not been independently reviewed or confirmed by sources other than the company's own website; the description above reflects company statements rather than independently verified specifications.
The company has also stated that it develops its own electromyography sensors, marketed under the name MyoUnit, which it says are intended to improve the speed and accuracy of muscle-signal detection.[39]
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- promotional language: see Words to watch;
- personal commentary: opinions or direct addresses to the reader;
- informal language.
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject.